CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors

NCT00949624 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: CP-868,596
DRUG: Docetaxel
DRUG: CP-868,596
DRUG: Docetaxel
DRUG: CP-868,596
DRUG: Docetaxel
DRUG: CP-868,596
DRUG: AG-013736
DRUG: Docetaxel

Sponsor

Arog Pharmaceuticals, Inc.